Calidi Biotherapeutics

We are committed to being at the forefront of cutting-edge research and innovation in the realm of oncology and arming the immune system to kill cancer. The company was founded in 2014, and is based in San Diego, California. In 2016, Calidi acquired our wholly-owned subsidiary, based in Bernried, Germany, which is a pillar in the company's Research & Development and Process Development activities. Our “off the shelf” stem cells deliver a viral payload that first kills cancer cells locally, and then supercharges the immune system to fight metastatic disease. Explore Calidi Biotherapeutics' robust and evolving lineup of innovative immunotherapies, each designed with precision and a vision for a healthier future. A blend of experts and innovators, each member plays a pivotal role in our mission to redefine cancer treatment. These oncology experts are among the country’s preeminent leaders in cancer biology and clinical care and join the company’s existing advisors who hail from top cancer research institutions and facilities collaborating with Calidi in the development of its novel immunotherapies targeting high-grade gliomas and solid tumors.